Works matching IS 00071048 AND DT 2022 AND VI 198 AND IP 1

Results: 33
    1

    Corrigendum.

    Published in:
    2022
    Publication type:
    Correction Notice
    2

    Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 209, doi. 10.1111/bjh.18219
    By:
    • McLornan, Donal P.;
    • Gras, Luuk;
    • Martin, Ivonne;
    • Sirait, Tiarlan;
    • Schroeder, Thomas;
    • Blau, Igor Wolfgang;
    • Kuball, Jürgen;
    • Byrne, Jenny;
    • Collin, Matthew;
    • Stadler, Michael;
    • Desmier, Déborah;
    • Salmenniemi, Urpu;
    • Jindra, Pavel;
    • Mikhailova, Natalia;
    • Lenhoff, Stig;
    • Rifón, Jose;
    • Robin, Marie;
    • Rovira, Montserrat;
    • Veelken, Hendrik;
    • Sadowska‐Klasa, Alicja
    Publication type:
    Article
    3
    4
    5

    Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5‐year analysis of the French early access program (EPA).

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 203, doi. 10.1111/bjh.18198
    By:
    • Manson, Guillaume;
    • Herbaux, Charles;
    • Schiano, Jean‐Marc;
    • Casasnovas, Olivier;
    • Stamatoullas, Aspasia;
    • Deau, Bénédicte;
    • Schmitt, Anna;
    • Regny, Caroline;
    • Bouabdallah, Krimo;
    • Chauchet, Adrien;
    • Ghesquieres, Hervé;
    • Tempescul, Adrian;
    • Dulery, Remy;
    • Nicolas‐Virelizier, Emmanuelle;
    • Delmer, Alain;
    • Borel, Cecile;
    • Dercle, Laurent;
    • Brice, Pauline;
    • Houot, Roch
    Publication type:
    Article
    6

    Donor‐transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 199, doi. 10.1111/bjh.18194
    By:
    • Ghandili, Susanne;
    • Kluger, Malte A.;
    • Leitner, Theo;
    • Grahammer, Florian;
    • Kirchner, Lennart;
    • Modemann, Franziska;
    • Achilles, Eike‐Gert;
    • Kreipe, Hans H.;
    • Klein, Janin;
    • Steinemann, Doris;
    • Wolschke, Christine;
    • Fischer, Lutz;
    • Bokemeyer, Carsten;
    • Fiedler, Walter;
    • Huber, Tobias B.;
    • Alsdorf, Winfried H.;
    • Mahmud, Maida
    Publication type:
    Article
    7
    8
    9

    Chemotherapy after PD‐1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 82, doi. 10.1111/bjh.18183
    By:
    • Calabretta, Eleonora;
    • Guidetti, Anna;
    • Ricci, Francesca;
    • Di Trani, Martina;
    • Monfrini, Chiara;
    • Magagnoli, Massimo;
    • Bramanti, Stefania;
    • Maspero, Davide;
    • Morello, Lucia;
    • Merli, Michele;
    • Di Rocco, Alice;
    • Graudenzi, Alex;
    • Derenzini, Enrico;
    • Antoniotti, Marco;
    • Rossi, Davide;
    • Corradini, Paolo;
    • Santoro, Armando;
    • Carlo‐Stella, Carmelo
    Publication type:
    Article
    10
    11
    12
    13
    14

    Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 24, doi. 10.1111/bjh.18176
    By:
    • Achini‐Gutzwiller, Federica R.;
    • Snowden, John A.;
    • Corbacioglu, Selim;
    • Greco, Raffaella;
    • Alexander, Tobias;
    • Snowden, John;
    • Badoglio, Manuela;
    • Labopin, Myriam;
    • Abinun, Mario;
    • Apte, Shashikant;
    • Arnold, Renate;
    • Domenech, Ariadna;
    • Brierley, Charlotte;
    • Burman, Joachim;
    • Castilla‐Llorente, Cristina;
    • Cooper, Nichola;
    • Daghia, Giulia;
    • Daikeler, Thomas;
    • del Papa, Nicoletta;
    • de Vries‐Bouwstra, Jeska
    Publication type:
    Article
    15
    16
    17
    18

    Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 93, doi. 10.1111/bjh.18172
    By:
    • LeBlanc, Richard;
    • Mian, Hira;
    • Reece, Donna;
    • Masih‐Khan, Esther;
    • Kardjadj, Moustafa;
    • Jimenez‐Zepeda, Victor H.;
    • McCurdy, Arleigh;
    • Song, Kevin;
    • Sebag, Michael;
    • Louzada, Martha;
    • White, Darrell;
    • Stakiw, Julie;
    • Kotb, Rami;
    • Reiman, Anthony;
    • Aslam, Muhammad;
    • Gul, Engin;
    • Venner, Christopher P.
    Publication type:
    Article
    19
    20

    International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newborn.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 183, doi. 10.1111/bjh.18170
    By:
    • Lieberman, Lani;
    • Lopriore, Enrico;
    • Baker, Jillian M.;
    • Bercovitz, Rachel S.;
    • Christensen, Robert D.;
    • Crighton, Gemma;
    • Delaney, Meghan;
    • Goel, Ruchika;
    • Hendrickson, Jeanne E.;
    • Keir, Amy;
    • Landry, Denise;
    • La Rocca, Ursula;
    • Lemyre, Brigitte;
    • Maier, Rolf F.;
    • Muniz‐Diaz, Eduardo;
    • Nahirniak, Susan;
    • New, Helen V.;
    • Pavenski, Katerina;
    • dos Santos, Maria Cristina Pessoa;
    • Ramsey, Glenn
    Publication type:
    Article
    21
    22

    Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation‐ineligible relapsed and refractory diffuse large B‐cell lymphoma.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 73, doi. 10.1111/bjh.18166
    By:
    • Paszkiewicz‐Kozik, Ewa;
    • Michalski, Wojciech;
    • Taszner, Michał;
    • Mordak‐Domagała, Monika;
    • Romejko‐Jarosińska, Joanna;
    • Knopińska‐Posłuszny, Wanda;
    • Najda, Jacek;
    • Borawska, Anna;
    • Chełstowska, Monika;
    • Świerkowska, Monika;
    • Dąbrowska‐Iwanicka, Anna;
    • Malenda, Agata;
    • Druzd‐Sitek, Agnieszka;
    • Konecki, Robert;
    • Kumiega, Beata;
    • Osowiecki, Michał;
    • Ostrowska, Beata;
    • Szpila, Tomasz;
    • Szymański, Marcin;
    • Targoński, Łukasz
    Publication type:
    Article
    23

    An inherited gain‐of‐function risk allele in EPOR predisposes to familial JAK2<sup>V617F</sup> myeloproliferative neoplasms.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 131, doi. 10.1111/bjh.18165
    By:
    • Rabadan Moraes, Graciela;
    • Pasquier, Florence;
    • Marzac, Christophe;
    • Deconinck, Eric;
    • Damanti, Carlotta Caterina;
    • Leroy, Gwendoline;
    • El‐Khoury, Mira;
    • El Nemer, Wassim;
    • Kiladjian, Jean‐Jacques;
    • Raslova, Hana;
    • Najman, Albert;
    • Vainchenker, William;
    • Marty, Caroline;
    • Bellanné‐Chantelot, Christine;
    • Plo, Isabelle
    Publication type:
    Article
    24

    Measurement of erythrocyte membrane mannoses to assess splenic function.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 155, doi. 10.1111/bjh.18164
    By:
    • Cao, Huan;
    • Mathur, Abhinav;
    • Robertson, Charlotte;
    • Antonopoulos, Aristotelis;
    • Henderson, Sadie;
    • Girard, Louis‐Pierre;
    • Wong, Jin Hien;
    • Davie, Adam;
    • Wright, Sonja;
    • Brewin, John;
    • Rees, David C.;
    • Dell, Anne;
    • Haslam, Stuart M.;
    • Vickers, Mark A.
    Publication type:
    Article
    25

    Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 114, doi. 10.1111/bjh.18163
    By:
    • Buesche, Guntram;
    • Teoman, Huesniye;
    • Schneider, Rebekka K.;
    • Ribezzo, Flavia;
    • Ebert, Benjamin L.;
    • Giagounidis, Aristoteles;
    • Göhring, Gudrun;
    • Schlegelberger, Brigitte;
    • Bock, Oliver;
    • Ganser, Arnold;
    • Aul, Carlo;
    • Germing, Ulrich;
    • Kreipe, Hans
    Publication type:
    Article
    26
    27
    28

    Activity and toxicity of intramuscular 1000 iu/m<sup>2</sup> polyethylene glycol‐E. coliL‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 142, doi. 10.1111/bjh.18158
    By:
    • Sidhu, Jasmeet;
    • Masurekar, Ashish Narayan;
    • Gogoi, Manash Pratim;
    • Fong, Caroline;
    • Ioannou, Tasos;
    • Lodhi, Taha;
    • Parker, Catriona;
    • Liu, Jizhong;
    • Kirkwood, Amy A.;
    • Moorman, Anthony V.;
    • Das, Kiranmoy;
    • Goulden, Nicholas J.;
    • Vora, Ajay;
    • Saha, Vaskar;
    • Krishnan, Shekhar
    Publication type:
    Article
    29
    30
    31

    Clonal haematopoiesis as a risk factor for therapy‐related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo‐(immuno)therapy.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 103, doi. 10.1111/bjh.18129
    By:
    • Voso, Maria‐Teresa;
    • Pandzic, Tatjana;
    • Falconi, Giulia;
    • Denčić‐Fekete, Marija;
    • De Bellis, Eleonora;
    • Scarfo, Lydia;
    • Ljungström, Viktor;
    • Iskas, Michail;
    • Del Poeta, Giovanni;
    • Ranghetti, Pamela;
    • Laidou, Stamatia;
    • Cristiano, Antonio;
    • Plevova, Karla;
    • Imbergamo, Silvia;
    • Engvall, Marie;
    • Zucchetto, Antonella;
    • Salvetti, Chiara;
    • Mauro, Francesca R.;
    • Stavroyianni, Niki;
    • Cavelier, Lucia
    Publication type:
    Article
    32
    33

    Issue Information.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 1, p. 3, doi. 10.1111/bjh.17595
    Publication type:
    Article